Additional US installations and new order from Codonics

16 September 2022 - 15:45

Pharmacolog's partner, Codonics Inc. recently delivered six WasteLog™ units to new hospitals and placed an additional order for nine WasteLog™ units for immediate delivery.

Pharmacolog's exclusive distributor and strategic partner Codonics, Cleveland, Ohio continues to supply WasteLog™ units to leading hospitals in the United States. Codonics has also ordered an additional nine WasteLog™ units from Pharmacolog for immediate delivery. Order value is approximately 2 MSEK.

The risk of narcotic drugs ending up in the wrong hands, so-called Drug Diversion, is a serious problem in healthcare. Every healthcare facility is vulnerable to Drug Diversion and must have a robust program to prevent it from occurring. An important part of such a program is an efficient and reliable waste control process. Interest in analytical equipment for waste screening of narcotic preparations is growing steadily and as a result Pharmacolog and Codonics are experiencing increased demand for WasteLog™.

Mats Högberg, CEO Pharmacolog comments: "Codonics is doing a fantastic job of marketing our solutions and we are now starting to see the results of the market launch at the end of last year. The number of inquiries is growing rapidly as the demand for efficient systems for so-called waste screening increases. Both companies are grateful to be part of the solution that helps prevent opioid and other drug abuse among healthcare professionals.”

For more information contact:

Mats Högberg, CEO

Email: [email protected]
Phone: +46
70-546 50 21

This information is insider information that Pharmacolog AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication through the agency of the contact person set out above, on September 16, 2022 at 15:45.

About Pharmacolog AB

Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.

The following trademarks are owned and protected by Pharmacolog i Uppsala AB: Pharmacolog™-logo, DrugLog™, WasteLog™, PrepLog™ and Pharmacolog Dashboard™.

Further information regarding the company is available at

The company's Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through [email protected].

Provided by: Cision
Nasdaq First North GM Stockholm (Sweden)
Pharmacolog i Uppsala AB
Pharmacolog i Uppsala develops systems and solutions that aim to optimize and ensure correct and effective treatment with injectable drugs. Its products include WasteLog, DrugLog, and PrepLog, which are aimed at a large number of treatment areas, such as; oncology, infectious diseases, and intensive care....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More